Education
About Us
Working with TipRanks
Follow Us
NUMG - ETF AI Analysis
Top Page
Nuveen ESG Mid-Cap Growth ETF (NUMG)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Top Holdings Performance
Most of the largest positions have shown strong gains this year, which has helped support the fund despite recent weakness.
Sector Diversification Across Growth Areas
The ETF spreads its investments across technology, industrials, health care, consumer cyclical, and other sectors, reducing reliance on any single industry.
Moderate Expense Ratio
The fund’s fee level is reasonable for an actively screened ESG mid-cap growth strategy, allowing investors to keep more of their returns compared with higher-cost funds.
Negative Factors
Recent Weak Overall Performance
The ETF has delivered weak returns over the past month, three months, and year to date, which may concern investors looking for near-term momentum.
Single-Stock Risk in Top Holdings
A meaningful portion of the portfolio is concentrated in a handful of names, so a downturn in one or two key holdings could noticeably hurt results.
Heavy U.S.-Only Exposure
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is highly tied to the U.S. market’s fortunes.
NUMG vs. SPDR S&P 500 ETF (SPY)
AUM360.62M
RegionNorth America
Expense Ratio0.31%
Beta1.13
IssuerNuveen
Inception DateDec 13, 2016
Dividend Yield0.01%
Asset ClassEquity
Index TrackedMSCI Nuveen ESG USA Mid Cap Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume45,232
30 Day Avg. Volume33,581
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.69Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering42
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NUMG Summary
Nuveen ESG Mid-Cap Growth ETF (NUMG) tracks the MSCI Nuveen ESG USA Mid Cap Growth Index, focusing on medium‑sized U.S. companies that are growing quickly and meet environmental, social, and governance (ESG) standards. It holds businesses like Ulta Beauty and Carvana, along with many tech, industrial, and health care names, giving investors a diversified way to seek long‑term growth while supporting more responsible corporate practices. This fund can be attractive for investors who want growth plus an ESG tilt, but its share price can rise and fall sharply with the stock market and mid‑cap growth stocks in particular.
How much will it cost me?The Nuveen ESG Mid-Cap Growth ETF (NUMG) has an expense ratio of 0.31%, which means you’ll pay $3.10 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed, focusing on selecting mid-cap growth companies that meet strict ESG criteria.
What would affect this ETF?The Nuveen ESG Mid-Cap Growth ETF (NUMG) could benefit from increased interest in ESG investing and the growth potential of mid-cap companies, particularly in sectors like Technology and Health Care, which are known for innovation. However, it may face challenges from economic downturns, rising interest rates that could impact growth stocks, or regulatory changes affecting ESG criteria. Its focus on U.S. mid-cap stocks also makes it sensitive to domestic economic conditions and sector-specific trends.
NUMG Top 10 Holdings
NUMG is leaning hard into U.S. mid-cap growth, with a clear tilt toward industrial and tech-driven names. Comfort Systems, Ciena, and EMCOR are doing much of the heavy lifting, with their shares rising and helping power the fund’s recent momentum. Steadier contributors like WW Grainger and Ulta Beauty act as ballast rather than rocket fuel. On the flip side, Idexx Laboratories, Alnylam Pharma, and especially Carvana are losing steam, creating a bit of drag. Overall, performance is being driven more by industrial strength than flashy mega-cap tech.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Quanta Services | 5.69% | $20.12M | $82.17B | 128.00% | 78 Outperform | |
| Idexx Laboratories | 3.94% | $13.94M | $49.28B | 44.26% | 78 Outperform | |
| WW Grainger | 3.92% | $13.86M | $54.28B | 15.05% | 73 Outperform | |
| Comfort Systems | 3.91% | $13.84M | $47.42B | 310.92% | 80 Outperform | |
| Ciena | 3.89% | $13.76M | $42.34B | 337.38% | 70 Outperform | |
| Axon Enterprise | 3.82% | $13.53M | $45.87B | 14.26% | 58 Neutral | |
| Alnylam Pharma | 3.44% | $12.16M | $42.51B | 29.17% | 60 Neutral | |
| Carvana Co | 3.30% | $11.68M | $72.47B | 77.23% | 66 Neutral | |
| Fair Isaac | 3.12% | $11.04M | $34.99B | -18.80% | 69 Neutral | |
| Datadog | 3.07% | $10.87M | $43.14B | 9.78% | 69 Neutral |
NUMG Technical Analysis
Negative
―
Price Trends
46.00
Negative
46.82
Negative
47.51
Negative
Market Momentum
-0.54
Negative
44.98
Neutral
70.11
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NUMG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 43.58, equal to the 50-day MA of 46.00, and equal to the 200-day MA of 47.51, indicating a neutral trend. The MACD of -0.54 indicates Negative momentum. The RSI at 44.98 is Neutral, neither overbought nor oversold. The STOCH value of 70.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NUMG.
NUMG Peer Comparison
Comparison Results
Performance Comparison
NUMG
Nuveen ESG Mid-Cap Growth ETF
43.35
0.63
1.47%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
―
―
―
RFG
Invesco S&P Midcap 400 Pure Growth ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
TMFM
Motley Fool Mid-Cap Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents